Literature DB >> 31932517

Multiple cause of death analysis in multiple sclerosis: A population-based study.

Katharine Harding1, Feng Zhu1, Mohammed Alotaibi1, Thomas Duggan1, Helen Tremlett1, Elaine Kingwell2.   

Abstract

OBJECTIVE: To gain a better understanding of the complex patterns of causes that contribute to death due to multiple sclerosis (MS) by assessing the relationship between MS and other causes of death listed on death certificates.
METHODS: Multiple cause of death data for all adult deaths (aged ≥18 years) in British Columbia, Canada, between 1986 and 2013 were accessed. All causes, as listed on the death certificate, whether underlying or contributing, were considered "any mention" causes. The associations between mention of MS on the death certificate and mention of other causes of death were examined by logistic regression, adjusted for age, sex, and calendar year (Bonferroni-corrected α level = 0.002). Findings were also sex-stratified.
RESULTS: Among 771,288 deaths, MS was mentioned on 2,153 certificates. If MS was mentioned (versus not mentioned), there was a greater chance that specific conditions contributed to the death: respiratory infection (adjusted odds ratio [aOR], 3.03 [95% confidence interval (CI), 2.73-3.36]), aspiration pneumonia (aOR, 7.15 [95% CI, 6.23-8.22]), urinary tract infection (UTI) (aOR, 10.2 [95% CI, 8.7-12.0]), other infection including sepsis (aOR, 1.34 [95% CI, 1.15-1.56]), and skin disease (aOR, 5.06 [95% CI, 3.96-6.46]). Sex differences existed for urinary tract infection (men: aOR, 14.9 [95% CI, 11.5-19.3]; women: aOR, 8.00 [95% CI, 6.53-9.81]) and chronic respiratory disease (men = aOR, 1.36 [95% CI, 1.14-1.63]; women = aOR, 0.97 [95% CI, 0.84-1.13]).
CONCLUSIONS: Deaths attributed to MS were commonly caused by infection (especially respiratory and urinary tract-related); conditions associated with advanced disability and immobility, such as aspiration pneumonia; and chronic respiratory disease in men. All are potentially modifiable; interventions that reduce the frequency or severity of these complications could improve survival in MS.
© 2020 American Academy of Neurology.

Entities:  

Mesh:

Year:  2020        PMID: 31932517      PMCID: PMC7136054          DOI: 10.1212/WNL.0000000000008907

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  35 in total

Review 1.  Mortality in multiple sclerosis: a review.

Authors:  P Ragonese; P Aridon; G Salemi; M D'Amelio; G Savettieri
Journal:  Eur J Neurol       Date:  2008-02       Impact factor: 6.089

2.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.

Authors:  B G Weinshenker; B Bass; G P Rice; J Noseworthy; W Carriere; J Baskerville; G C Ebers
Journal:  Brain       Date:  1989-02       Impact factor: 13.501

3.  Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.

Authors:  E Kingwell; M van der Kop; Y Zhao; A Shirani; F Zhu; J Oger; H Tremlett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-08-23       Impact factor: 10.154

4.  Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis.

Authors:  Yvan Jamilloux; Delphine Maucort-Boulch; Sébastien Kerever; Mathieu Gerfaud-Valentin; Christiane Broussolle; Mireille Eb; Dominique Valeyre; Pascal Seve
Journal:  Eur Respir J       Date:  2016-09-22       Impact factor: 16.671

5.  Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.

Authors:  Michael J Goldacre; Marie Duncan; Myfanwy Griffith; Martin R Turner
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

Review 6.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

Authors:  Betsy Foxman
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

7.  Fracture-related mortality in southern Sweden: A multiple cause of death analysis, 1998-2014.

Authors:  Aliasghar A Kiadaliri; Björn E Rosengren; Martin Englund
Journal:  Injury       Date:  2017-12-09       Impact factor: 2.586

8.  Multiple causes of death analysis of chronic diseases: the example of diabetes.

Authors:  Ugo Fedeli; Giacomo Zoppini; Carlo Alberto Goldoni; Francesco Avossa; Giuseppe Mastrangelo; Mario Saugo
Journal:  Popul Health Metr       Date:  2015-08-25

9.  Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.

Authors:  Hanne Marie Bøe Lunde; Jörg Assmus; Kjell-Morten Myhr; Lars Bø; Nina Grytten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-04-01       Impact factor: 10.154

10.  A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city.

Authors:  Elizabeth M Visser; Katie Wilde; James F Wilson; Karl K Yong; Carl E Counsell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-05-10       Impact factor: 10.154

View more
  5 in total

1.  Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study.

Authors:  Nabil Seery; Sifat Sharmin; Vivien Li; Ai-Lan Nguyen; Claire Meaton; Roberts Atvars; Nicola Taylor; Kelsey Tunnell; John Carey; Mark P Marriott; Katherine A Buzzard; Izanne Roos; Chris Dwyer; Josephine Baker; Lisa Taylor; Kymble Spriggs; Trevor J Kilpatrick; Tomas Kalincik; Mastura Monif
Journal:  CNS Drugs       Date:  2021-04-13       Impact factor: 5.749

2.  Autoimmunity Increases Susceptibility to and Mortality from Sepsis.

Authors:  Isaac J Jensen; Samantha N Jensen; Patrick W McGonagill; Thomas S Griffith; Ashutosh K Mangalam; Vladimir P Badovinac
Journal:  Immunohorizons       Date:  2021-10-26

3.  Association of multiple sclerosis with mortality in sepsis: a population-level analysis.

Authors:  Lavi Oud; John Garza
Journal:  J Intensive Care       Date:  2022-07-25

4.  The effect of applying the nursing process based on the Theory of Goal Attainment on activities of daily living and quality of life in persons with multiple sclerosis during COVID-19 pandemic: a clinical trial.

Authors:  Firuzeh Payamani; Mahnaz Khatiban; Alireza Soltanian; Masoud Ghiasian; Seyed Reza Borzou
Journal:  Ir J Med Sci       Date:  2022-07-25       Impact factor: 2.089

Review 5.  Sepsis and multiple sclerosis: Causative links and outcomes.

Authors:  Đorđe Miljković; Suzana Stanisavljević; Isaac J Jensen; Thomas S Griffith; Vladimir P Badovinac
Journal:  Immunol Lett       Date:  2021-07-25       Impact factor: 4.230

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.